Washington [US], September 18 (ANI): Patients with metastatic hormone receptor-positive breast cancer who have low activity levels of the enzyme sTK1 in their blood serum at the start of anti-estrogen treatment live longer and go longer without their disease progressing than patients with hi
Washington [US], September 15 (ANI): Researchers with the SWOG Cancer Research Network have found that patients with metastatic hormone receptor-positive breast cancer who have low activity levels of the enzyme sTK1 in their blood serum at the start of anti-estrogen treatment live longer and
Madrid [Spain], July 18 (ANI): Scientists, during a recent study discovered combining BRAF oncogene inhibitors and chemotherapy, is a very effective strategy for fighting metastatic melanoma, which is the leading cause of death from skin cancer around the globe.
Madrid [Spain], July 13 (ANI): During a recent study, researchers found that combining BRAF oncogene inhibitors and chemotherapy is a very effective strategy for fighting metastatic melanoma, which is the leading cause of death from skin cancer around the globe.
Washington [US], February 15 (ANI): Recent research in a SWOG Cancer Research Network trial that put three targeted drugs to the test, found cabozantinib, which is a small molecule inhibitor, most effective in treating patients with metastatic papillary kidney cancer.
Washington [US], February 14 (ANI): In a SWOG Cancer Research Network trial that put three targeted drugs to the test, the small molecule inhibitor cabozantinib was found most effective in treating patients with metastatic papillary kidney cancer - findings expected to change medical practic
Massachusetts [US], February 14 (ANI): A new clinical study published in The New England Journal of Medicine today and simultaneously presented during the American Society of Clinical Oncology (ASCO) 2021 Genitourinary Cancers Symposium claims that a drug combination of Lenvatinib plus pemb
Adelaide [Australia], January 19 (ANI): Researchers at the University of Adelaide have found new evidence about the positive role of androgens in breast cancer treatment with immediate implications for women with estrogen receptor-driven metastatic disease.
Washington [US], January 9 (ANI): After defining extensive cellular heterogeneity, researchers from The University of Texas MD Anderson Cancer Center developed a tool that might be useful in stratifying patients with gastric cancer and directing them for more effective treatment strategies.
Washington [US], January 5 (ANI): Researchers from The University of Texas MD Anderson Cancer Center who profiled more than 45,000 individual cells from patients with peritoneal carcinomatosis (PC), defined the extensive cellular heterogeneity and identified two distinct subtypes correlated
Washington [US], October 24 (ANI): A new paper suggests that sometime in the future, scientists may be able to prevent cancer by controlling two proteins that operate deep inside the quagmire of epigenetic cell fate transitions.